ID
42790
Description
Ropinirole Case Report Form GSK RRL100013 GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage
Keywords
Versions (5)
- 10/5/17 10/5/17 -
- 2/22/18 2/22/18 -
- 2/22/18 2/22/18 -
- 2/22/18 2/22/18 -
- 9/17/21 9/17/21 -
Copyright Holder
gsk
Uploaded on
September 17, 2021
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Ropinirole Case Report Form GSK RRL100013
Ropinirole Case Report Form GSK RRL100013
Description
Other medication
Description
Prior Medication
Alias
- UMLS CUI-1
- C2826257
Description
(Trade Name Preferred)
Data type
text
Alias
- UMLS CUI [1]
- C2360065
Description
(e.g.500 mg)
Data type
integer
Alias
- UMLS CUI [1]
- C1960417
Description
Frequency of this Dose
Data type
integer
Alias
- UMLS CUI [1]
- C3476109
Description
Route
Data type
text
Alias
- UMLS CUI [1]
- C0013153
Description
Indication
Data type
text
Alias
- UMLS CUI [1,1]
- C3146298
- UMLS CUI [1,2]
- C0013227
Description
(e.g.6 years)
Data type
integer
Alias
- UMLS CUI [1]
- C0444921
Description
Day/Month/Year
Data type
date
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0806020
Description
Continuing at end of study
Data type
boolean
Alias
- UMLS CUI [1]
- C1562611
Similar models
Ropinirole Case Report Form GSK RRL100013
C0013231 (UMLS CUI [2])
C0013227 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
No comments